Saturday, September 5, 2015

GeneNews’ IDL to provide prostate testing to MD Anderson

GeneNews’ IDL to provide prostate testing to MD Anderson

September 4, 2015 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) Innovative Diagnostic Laboratory (IDL) joint venture has agreed to provide its prostate health index (PHI) testing services to MD Anderson Cancer Center. “There is significant interest in IDL’s early cancer diagnostic tests from hospital groups and large physician practice groups,” said James Howard-Tripp, executive chairman of GeneNews, said in a statement. “IDL […]

GeneNews names Dr. Joel Brill as CMO

GeneNews names Dr. Joel Brill as CMO

August 5, 2015 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has appointed Dr. Joel Brill as CMO of its Innovative Diagnostic Laboratory joint-venture. In his new role, Dr. Brill will assume leadership responsibility for the medical aspects of IDL’s laboratory, and act as the company’s medical lead with physicians, patients and insurance providers. Dr. Brill will serve on IDL’s executive committee as […]

GeneNews arranging private placement

GeneNews arranging private placement

July 15, 2015 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) is proposing to complete a private placement of up to 8,668,240 units at a price of 35 cents each for gross proceeds of slightly more than $3-million. Each unit consists of one common share and one-half of a warrant, with each whole warrant entitling the holder to purchase an additional common share […]

GeneNews in pact to increase stake in IDL venture

GeneNews in pact to increase stake in IDL venture

May 19, 2015 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has entered into a purchase agreement with Cobalt Healthcare Consultants to purchase Health Diagnostic Laboratory’s (HDL) one-third ownership stake in their Innovative Diagnostic Laboratory (IDL) joint venture for $4-million. Combined with prior investments in IDL, GeneNews and Cobalt will each own a 50% equity interest in the joint venture. GeneNews and Cobalt […]

GeneNews IDL JV test volume up 150% in Q1

GeneNews IDL JV test volume up 150% in Q1

May 14, 2015 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory (IDL), carried out a total of 39,500 tests in the first quarter this year, up about 150%, from 15,800 in the year earlier quarter. In a statement, James Howard-Tripp, executive chairman of GeneNews, said that with vital functions at IDL successfully brought in-house, “we remain committed […]

GeneNews IDL JV processed 150,000 tests in 2014

GeneNews IDL JV processed 150,000 tests in 2014

April 1, 2015 by · Leave a Comment 

Tweet Despite changes GeneNews (TSX:GEN) carried out to the overall operations and sales force at its Innovative Diagnostic Laboratory (IDL) joint venture, total test volumes were 97,400 in second half of 2014, up approximately 50% from 65,700 in the first half of the year. “In many respects, we only just crossed the starting line at […]

Study finds colorectal cancer in young patients to double

Study finds colorectal cancer in young patients to double

November 17, 2014 by · Leave a Comment 

Tweet In the next 15 years, more than one-in-10 colon cancers and nearly one-in-four rectal cancers will be diagnosed in patients younger than the traditional screening age, according to researchers at The University of Texas MD Anderson Cancer Center. The growing public health problem is underscored by data trends among 20- to 34-year-olds in the […]

GeneNews’ IDL JV lab tests climb in Q3

GeneNews’ IDL JV lab tests climb in Q3

November 12, 2014 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory, processed more than 50,600 tests during the third quarter this year. With a successful limited scale launch of IDL’s operations in the fourth quarter of 2013, full scale up activities began in the first quarter this year, including growing IDL’s lab capacity, increasing the size and […]

GeneNews’ IDL adds blood test for breast cancer prediction

GeneNews’ IDL adds blood test for breast cancer prediction

October 14, 2014 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has in-licensed two biomarker assays – sphingotest pro-NT and sphingotest pro-ENK – that aid physicians in identifying those females at highest risk for breast cancer in the general population. Both tests were developed by sphingotec GmbH of Germany, a biomarker assay developer, which has recently expanded in the U.S. GeneNews expects to […]

GeneNews Q2 JV lab test volumes more than triple sequentially

GeneNews Q2 JV lab test volumes more than triple sequentially

August 8, 2014 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory (IDL), processed 46,051 tests in the second quarter, up more than threefold sequentially from the 14,680 tests processed in the first quarter this year. “So far, that growth has continued into the third quarter,” GeneNews executive chairman James Howard-Tripp said in a statement. IDL’s menu of […]

Next Page »

Email Newsletters with Constant Contact
Google+